Our Publications

2019

Shorstova T, Marques M, Su J, Johnston J, Kleinman CL, Hamel N, Huang S, Alaoui-Jamali MA, Foulkes WD, Witcher M. SWI/SNF-compromised cancers are susceptible to bromodomain inhibitors. Cancer Res. 2019 Mar 15.CAN-18-1545. [Epub ahead of print]

Xue Y, Meehan B, Macdonald E, Venneti S, Wang X-Q, Witkowski L, Jelinic P, Kong T, Martinez D, Morin G, Firlit M, Abedini A, Johnson R, Cencic R, Patibandla J, Chen H, Papadakis A, Auguste A, de Rink I, Kerkhoven R, Bertos N, Gotlieb W, Clarke B, Leary A, Witcher M, Guiot M-C, Pelletier J, Dostie J, Park M, Judkins A, Hass R, Levine D, Rak J, Vanderhyden B, Foulkes W, and Huang S. CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary. Nat Commun. 2019 Feb;10(1):558

Xue Y, Meehan B, Fu Z, Wang XQD, Fiset P-O, Rieker R, Levins C, Kong T, Zhu X, Morin G, Skerritt L, Herpel E, Venneti S, Martinez D, Judkins AR, Jung S, Camilleri-Broet S, Gonzalez A-V, Guiot M-C, Lockwood W, Spicer J, Agaimy A, Pastor W, Dostie J, Rak J, Foulkes WD, Huang S. SMARCA4 loss is synthetic lethal with CDK4/6 inhibition in non-small cell lung cancer. Nat Commun. 2019 Feb;10(1):557

McCluggage WG, Chong AS, Attygalle AD, Clarke BA, Chapman W, Rivera B, Foulkes WD. Expanding the morphological spectrum of ovarian microcystic stromal tumour. Histopathology. 2019 Feb;74(3):443-451

Castellsagué E, Li R, Aligue R, González S, Sanz J, Martin E, Velasco À, Capellá G, Stewart CJR, Vidal A, Majewski J, Rivera B, Polak P, Matias-Guiu X, Brunet J, Foulkes WD. Novel POLE pathogenic germline variant in a family with multiple primary tumors results in distinct mutational signatures. Hum Mutat. 2019 Jan;40(1):36-41

2018

Chong AS, Fahiminiya S, Strother D, Priest J, Albrecht S, Rivera B, Foulkes WD. Revisiting pleuropulmonary blastoma and atypical choroid plexus papilloma in a young child: DICER1 syndrome or not? Pediatr Blood Cancer. 2018 Oct;65(10):e27294.

de Kock L, Fahiminiya S, Fiset PO, Astigarraga I, Nguyen VH, Albrecht S, Foulkes WD. Infantile Pulmonary Teratoid Tumor. N Engl J Med. 2018 Jun 7;378(23):2238-2240

de Kock L, Geoffrion D, Rivera B, Wagener R, Sabbaghian N, Bens S, Ellezam B, Bouron-Dal Soglio D, Ordóñez J, Sacharow S, Polo Nieto JF, Guillerman RP, Vujanic GM, Priest JR, Siebert R, Foulkes WD. Multiple DICER1-related tumors in a child with a large interstitial 14q32 deletion. Genes Chromosomes Cancer. 2018
May;57(5):223-230.

Apellaniz-Ruiz M, de Kock L, Sabbaghian N, Guaraldi F, Ghizzoni L, Beccuti G, Foulkes WD. Familial multinodular goiter and Sertoli-Leydig cell tumors associated with a large intragenic in-frame DICER1 deletion. Eur J Endocrinol. 2018 Feb;178(2):K11-K19.

Rivera B, Polak P, Foulkes WD. Monogenic Diseases of DNA Repair. N Engl J Med. 2018 Feb 1;378(5):491

Wu MK, Vujanic GM, Fahiminiya S, Watanabe N, Thorner PS, O’Sullivan MJ, Fabian MR, Foulkes WD. Anaplastic sarcomas of the kidney are characterized by DICER1 mutations. Mod Pathol. 2018 Jan;31(1):169-178.

2017

Polak P, Kim J, Tiao G, Foulkes WD, et al (2017) . A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancer. Nat Genet. 2017 Oct;49(10):1476-1486.

Foo TK, Tischkowitz M, Simhadri S, Boshari T, Zayed N, Burke KA, Foulkes WD, et al (2017). Compromised BRCA1-PALB2 interaction is associated with breast cancer risk. Oncogene. 2017 Jul 20;36(29):4161-4170.

Witkowski L, Donini N,  Foulkes WD (2017). et al (2017). The hereditary nature of small cell carcinoma of the ovary, hypercalcemic type: two new familial cases. Fam Cancer. 2017 Jul;16(3):395-399.

Wu MK, Vujanic GM, Fahiminiya S, Watanabe N, Foulkes WD, et al (2017). Anaplastic sarcomas of the kidney are characterized by DICER1 mutations. Mod Pathol. 2018 Jan;31(1):169-178.

Rivera B, Di Iorio M, Frankum J, Nadaf J, Fahiminiya S, Hamel N, Foulkes WD, et al (2017). Functionally Null RAD51D Missense Mutation Associates Strongly with Ovarian Carcinoma. Cancer Res. 2017 Aug 15;77(16):4517-4529.

de Kock L, Rivera B, Revil T, Thorner P, Goudie C, Foulkes WD, et al (2017). Sequencing of DICER1 in sarcomas identifies biallelic somatic DICER1 mutations in an adult-onset embryonal rhabdomyosarcoma. Br J Cancer. 2017 Jun 6;116(12):1621-1626.

2016

Rivera B, Gayden T, Carrot-Zhang J, Nadaf J, Boshari T, et al (2016). Germline and somatic FGFR1 abnormalities in dysembryoplastic neuroepithelial tumors. Acta Neuropathol 131, 847-63.

Foulkes WD, Gore M, McCluggage WG (2016). Rare non-epithelial ovarian neoplasms: Pathology, genetics, and treatment. Gynecol Oncol. 2016 Jul;142(1):190-8. Epub 2016 Apr 19.

Witkowski L, Goudie C, Ramos P, Boshari T, et al (2016). The influence of clinical and genetic factors on patient outcome in small cell carcinoma of the ovary, hypercalcemic type. Gynecol Oncol. 2016 Jun;141(3):454-60. 

Wu MK, de Kock L, Conwell LS, Stewart CJ, et al (2016). Functional characterization of multiple DICER1 mutations in an adolescent. Endocr Relat Cancer 23(2):L1-5.

de Kock L, Wang YC, Revil T, Badescu D, Rivera B, et al (2016). High-sensitivity sequencing reveals multi-organ somatic mosaicism causing DICER1 syndrome. J Med Genet 53(1):43-52. Featured on the cover of the January 2016 issue.

Foulkes WD, Knoppers BM, Turnbull C. Population genetic testing for cancer susceptibility: founder mutations to genomes. (2016). Nat Rev Clin Oncol 13(1):41-45. Review

2015

Li L, Hamel N, Baker K, et al (2015). A homozygous PMS2 founder mutation with an attenuated constitutional mismatch repair deficiency phenotype. J Med Genet 52, 348-52.

Cybulski C, Carrot-Zhang J, Kluźniak W, Rivera B, et al (2015). Germline RECQL mutations are associated with breast cancer susceptibility. Nat Genet 47, 643-6.

de Kock L, Druker H, Weber E, et al (2015). Ovarian embryonal rhabdomyosarcoma is a rare manifestation of the DICER1 syndrome. Hum Pathol 46, 917-22.

Castellsagué E, Liu J, Volenik A, Giroux S, et al (2015). Characterization of a novel founder MSH6 mutation causing Lynch syndrome in the French Canadian population. Clin Genet 87, 536-42.

Easton DF, Pharoah PD, Foulkes WD, et al (2015) Gene-panel sequencing and the prediction of breast-cancer risk. N Engl J Med 372, 2243-57.

Rivera B, Castellsagué E, Bah I, et al. Bi-allelic NTHL1 mutations in a woman with multiple primary tumors (2015). New Engl J Med 12;373(20):1985-6

2014

Witkowski L, Carrot-Zhang J, Albrecht S, et al (2014). Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type. Nat Genet 46, 438-443.

Foulkes WD, Priest JR and Duchaine TF (2014). DICER1: mutations, microRNAs, and mechanisms. Nat Rev Cancer 14, 662-672.

de Kock L, Sabbaghian N, Plourde F, et al (2014). Pituitary blastoma: a pathognomonic feature of germline DICER1 mutations. Acta Neuropathologica 128, 111-122.

Antoniou AC, Casadei S, Foulkes WD, et al (2014). Breast-cancer risk in families with mutations in PALB2. N Engl J Med 7, 497-506

de Kock L, Sabbaghian N, Druker H, et al (2014). Germ-line and somatic DICER1 mutations in pineoblastoma. Acta Neuropathologica 128, 583-595.